Fluoroquinolones: Mechanism of action, classification, and development of resistance

被引:253
作者
Blondeau, JM
机构
[1] Royal Univ Hosp, Dept Clin Microbiol, Saskatoon, SK S7N 0W8, Canada
[2] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada
[3] Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 0W0, Canada
关键词
antimicrobials; fluoroquinolones; mechanisms of action; ocular infections; resistance topoisomerases;
D O I
10.1016/j.survophthal.2004.01.005
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The fluoroquinolones represent an evolving class of broad-spectrum antimicrobial agents used in the prevention and treatment of a variety of ocular infections; however, resistance to currently available agents in the class has been emerging among ocular pathogens. This article reviews the mechanism of action of existing and new fluoroquinolones and discusses the structure-activity relationship of the fluoroquinolones as it relates to the classification of these compounds. This article also highlights the mechanism of resistance among common ocular pathogens and discusses the potential need for newer fluoroquinolones in ophthalmology. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:S73 / S78
页数:6
相关论文
共 39 条
[1]   The fluoroquinolone antibacterials: past, present and future perspectives [J].
Appelbaum, PC ;
Hunter, PA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (01) :5-15
[2]  
Ball P, 1998, Expert Opin Investig Drugs, V7, P761, DOI 10.1517/13543784.7.5.761
[3]  
Ball P, 2000, J ANTIMICROB CHEMOTH, V46, P17
[4]  
Blondeau JM, 1999, CLIN THER, V21, P3
[5]   A review of clinical trials with fluoroquinolones with an emphasis on new agents [J].
Blondeau, JM .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (02) :383-413
[6]   Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV [J].
Breines, DM ;
Ouabdesselam, S ;
Ng, EY ;
Tankovic, J ;
Shah, S ;
Soussy, CJ ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :175-179
[7]   Emerging ciprofloxacin-resistant Pseudomonas aeruginosa [J].
Chaudhry, NA ;
Flynn, HW ;
Murray, TG ;
Tabandeh, H ;
Mello, MO ;
Miller, D .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (04) :509-510
[8]   Dual activity of fluoroquinolones against Streptococcus pneumoniae [J].
Fisher, LM ;
Heaton, VJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) :463-464A
[9]   Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae [J].
Fukuda, H ;
Kishii, R ;
Takei, M ;
Hosaka, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1649-1653
[10]   Emerging fluoroquinolone resistance in bacterial keratitis - A 5-year review [J].
Goldstein, MH ;
Kowalski, RP ;
Gordon, YJ .
OPHTHALMOLOGY, 1999, 106 (07) :1313-1318